Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Seven medical personnel experienced severe fever and thrombocytopenia syndrome (SFTS) in a rare case of human-to-human ...

A recent trial reveals that nivolumab combined with chemotherapy significantly improves survival rates in older patients with ...

Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...

Meropenem is a broad-spectrum carbapenem widely used to treat both Gram-positive and negative bacterial infections, including extended-spectrum beta-lactamase-producing microbes. We describe the ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Gyre Therapeutics has a unique business model for evaluating and commercializing drugs in China. Find out why GYRE stock is a ...

John Mascarenhas, MD, discusses phase 1 data showing that INCA33989 is a well-tolerated therapy for calreticulin–mutant essential thrombocythemia, with early signs of efficacy and potential disease ...

Letter Published: March 2000 Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1 Kim E. Nichols, John D. Crispino, Mortimer Poncz, James G. White, Stuart ...

Biphasic anaphylaxis is a secondary anaphylactic reaction. Get the facts on symptoms, risk factors, prevention, and more.

Background Thrombocytopenia is a poorly understood complication after surgical (mechanical or biological) (SAVR) and transcatheter aortic valve replacement (TAVR). The etiology of this platelet count ...

The Clair-Maltby Secondary Plan has been approved by the Ontario Land Tribunal and is in effect as of March 6, 2024. Clair-Maltby Secondary Plan Clair-Maltby will be a vibrant, urban community that is ...